Global Liver Failure Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 120832
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Liver Failure Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Liver Failure Therapeutics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Clinic accounting for % of the Liver Failure Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Ornithine Phenylacetate segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Liver Failure Therapeutics include Alfact Innovation, BioLineRx Ltd, Cell2B Advanced Therapeutics SA, Conatus Pharmaceuticals Inc, and Immune Pharmaceuticals Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Liver Failure Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Ornithine Phenylacetate

MTL-CEBPA

F-573

BL-1220

PP-100

Others

Market segment by Application, can be divided into

Clinic

Hospital

Others

Market segment by players, this report covers

Alfact Innovation

BioLineRx Ltd

Cell2B Advanced Therapeutics SA

Conatus Pharmaceuticals Inc

Immune Pharmaceuticals Inc

Mina Therapeutics Ltd

Mylan NV

Ocera Therapeutics Inc

PledPharma AB

Promethera Biosciences SA

Silence Therapeutics Plc

Unicyte AG

Ventria Bioscience

Vital Therapies Inc

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Liver Failure Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Liver Failure Therapeutics, with revenue, gross margin and global market share of Liver Failure Therapeutics from 2019 to 2022.

Chapter 3, the Liver Failure Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Liver Failure Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Liver Failure Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Liver Failure Therapeutics

1.2 Classification of Liver Failure Therapeutics by Type

1.2.1 Overview: Global Liver Failure Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Liver Failure Therapeutics Revenue Market Share by Type in 2021

1.2.3 Ornithine Phenylacetate

1.2.4 MTL-CEBPA

1.2.5 F-573

1.2.6 BL-1220

1.2.7 PP-100

1.2.8 Others

1.3 Global Liver Failure Therapeutics Market by Application

1.3.1 Overview: Global Liver Failure Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Global Liver Failure Therapeutics Market Size & Forecast

1.5 Global Liver Failure Therapeutics Market Size and Forecast by Region

1.5.1 Global Liver Failure Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Liver Failure Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America Liver Failure Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe Liver Failure Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Liver Failure Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America Liver Failure Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Liver Failure Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Liver Failure Therapeutics Market Drivers

1.6.2 Liver Failure Therapeutics Market Restraints

1.6.3 Liver Failure Therapeutics Trends Analysis

2 Company Profiles

2.1 Alfact Innovation

2.1.1 Alfact Innovation Details

2.1.2 Alfact Innovation Major Business

2.1.3 Alfact Innovation Liver Failure Therapeutics Product and Solutions

2.1.4 Alfact Innovation Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Alfact Innovation Recent Developments and Future Plans

2.2 BioLineRx Ltd

2.2.1 BioLineRx Ltd Details

2.2.2 BioLineRx Ltd Major Business

2.2.3 BioLineRx Ltd Liver Failure Therapeutics Product and Solutions

2.2.4 BioLineRx Ltd Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 BioLineRx Ltd Recent Developments and Future Plans

2.3 Cell2B Advanced Therapeutics SA

2.3.1 Cell2B Advanced Therapeutics SA Details

2.3.2 Cell2B Advanced Therapeutics SA Major Business

2.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product and Solutions

2.3.4 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Cell2B Advanced Therapeutics SA Recent Developments and Future Plans

2.4 Conatus Pharmaceuticals Inc

2.4.1 Conatus Pharmaceuticals Inc Details

2.4.2 Conatus Pharmaceuticals Inc Major Business

2.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions

2.4.4 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Conatus Pharmaceuticals Inc Recent Developments and Future Plans

2.5 Immune Pharmaceuticals Inc

2.5.1 Immune Pharmaceuticals Inc Details

2.5.2 Immune Pharmaceuticals Inc Major Business

2.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions

2.5.4 Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Immune Pharmaceuticals Inc Recent Developments and Future Plans

2.6 Mina Therapeutics Ltd

2.6.1 Mina Therapeutics Ltd Details

2.6.2 Mina Therapeutics Ltd Major Business

2.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Product and Solutions

2.6.4 Mina Therapeutics Ltd Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Mina Therapeutics Ltd Recent Developments and Future Plans

2.7 Mylan NV

2.7.1 Mylan NV Details

2.7.2 Mylan NV Major Business

2.7.3 Mylan NV Liver Failure Therapeutics Product and Solutions

2.7.4 Mylan NV Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Mylan NV Recent Developments and Future Plans

2.8 Ocera Therapeutics Inc

2.8.1 Ocera Therapeutics Inc Details

2.8.2 Ocera Therapeutics Inc Major Business

2.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Product and Solutions

2.8.4 Ocera Therapeutics Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Ocera Therapeutics Inc Recent Developments and Future Plans

2.9 PledPharma AB

2.9.1 PledPharma AB Details

2.9.2 PledPharma AB Major Business

2.9.3 PledPharma AB Liver Failure Therapeutics Product and Solutions

2.9.4 PledPharma AB Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 PledPharma AB Recent Developments and Future Plans

2.10 Promethera Biosciences SA

2.10.1 Promethera Biosciences SA Details

2.10.2 Promethera Biosciences SA Major Business

2.10.3 Promethera Biosciences SA Liver Failure Therapeutics Product and Solutions

2.10.4 Promethera Biosciences SA Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Promethera Biosciences SA Recent Developments and Future Plans

2.11 Silence Therapeutics Plc

2.11.1 Silence Therapeutics Plc Details

2.11.2 Silence Therapeutics Plc Major Business

2.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Product and Solutions

2.11.4 Silence Therapeutics Plc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Silence Therapeutics Plc Recent Developments and Future Plans

2.12 Unicyte AG

2.12.1 Unicyte AG Details

2.12.2 Unicyte AG Major Business

2.12.3 Unicyte AG Liver Failure Therapeutics Product and Solutions

2.12.4 Unicyte AG Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Unicyte AG Recent Developments and Future Plans

2.13 Ventria Bioscience

2.13.1 Ventria Bioscience Details

2.13.2 Ventria Bioscience Major Business

2.13.3 Ventria Bioscience Liver Failure Therapeutics Product and Solutions

2.13.4 Ventria Bioscience Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Ventria Bioscience Recent Developments and Future Plans

2.14 Vital Therapies Inc

2.14.1 Vital Therapies Inc Details

2.14.2 Vital Therapies Inc Major Business

2.14.3 Vital Therapies Inc Liver Failure Therapeutics Product and Solutions

2.14.4 Vital Therapies Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Vital Therapies Inc Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Liver Failure Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Liver Failure Therapeutics Players Market Share in 2021

3.2.2 Top 10 Liver Failure Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Liver Failure Therapeutics Players Head Office, Products and Services Provided

3.4 Liver Failure Therapeutics Mergers & Acquisitions

3.5 Liver Failure Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Liver Failure Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global Liver Failure Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Liver Failure Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global Liver Failure Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Liver Failure Therapeutics Revenue by Type (2017-2028)

6.2 North America Liver Failure Therapeutics Revenue by Application (2017-2028)

6.3 North America Liver Failure Therapeutics Market Size by Country

6.3.1 North America Liver Failure Therapeutics Revenue by Country (2017-2028)

6.3.2 United States Liver Failure Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada Liver Failure Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico Liver Failure Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Liver Failure Therapeutics Revenue by Type (2017-2028)

7.2 Europe Liver Failure Therapeutics Revenue by Application (2017-2028)

7.3 Europe Liver Failure Therapeutics Market Size by Country

7.3.1 Europe Liver Failure Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany Liver Failure Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France Liver Failure Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Liver Failure Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia Liver Failure Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy Liver Failure Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Liver Failure Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific Liver Failure Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific Liver Failure Therapeutics Market Size by Region

8.3.1 Asia-Pacific Liver Failure Therapeutics Revenue by Region (2017-2028)

8.3.2 China Liver Failure Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan Liver Failure Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea Liver Failure Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India Liver Failure Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Liver Failure Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia Liver Failure Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Liver Failure Therapeutics Revenue by Type (2017-2028)

9.2 South America Liver Failure Therapeutics Revenue by Application (2017-2028)

9.3 South America Liver Failure Therapeutics Market Size by Country

9.3.1 South America Liver Failure Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil Liver Failure Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina Liver Failure Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Liver Failure Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa Liver Failure Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa Liver Failure Therapeutics Market Size by Country

10.3.1 Middle East & Africa Liver Failure Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey Liver Failure Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Liver Failure Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE Liver Failure Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Liver Failure Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Liver Failure Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Liver Failure Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Liver Failure Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Liver Failure Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. Alfact Innovation Corporate Information, Head Office, and Major Competitors

Table 7. Alfact Innovation Major Business

Table 8. Alfact Innovation Liver Failure Therapeutics Product and Solutions

Table 9. Alfact Innovation Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. BioLineRx Ltd Corporate Information, Head Office, and Major Competitors

Table 11. BioLineRx Ltd Major Business

Table 12. BioLineRx Ltd Liver Failure Therapeutics Product and Solutions

Table 13. BioLineRx Ltd Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Cell2B Advanced Therapeutics SA Corporate Information, Head Office, and Major Competitors

Table 15. Cell2B Advanced Therapeutics SA Major Business

Table 16. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product and Solutions

Table 17. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Conatus Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors

Table 19. Conatus Pharmaceuticals Inc Major Business

Table 20. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions

Table 21. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Immune Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors

Table 23. Immune Pharmaceuticals Inc Major Business

Table 24. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions

Table 25. Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Mina Therapeutics Ltd Corporate Information, Head Office, and Major Competitors

Table 27. Mina Therapeutics Ltd Major Business

Table 28. Mina Therapeutics Ltd Liver Failure Therapeutics Product and Solutions

Table 29. Mina Therapeutics Ltd Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Mylan NV Corporate Information, Head Office, and Major Competitors

Table 31. Mylan NV Major Business

Table 32. Mylan NV Liver Failure Therapeutics Product and Solutions

Table 33. Mylan NV Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Ocera Therapeutics Inc Corporate Information, Head Office, and Major Competitors

Table 35. Ocera Therapeutics Inc Major Business

Table 36. Ocera Therapeutics Inc Liver Failure Therapeutics Product and Solutions

Table 37. Ocera Therapeutics Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. PledPharma AB Corporate Information, Head Office, and Major Competitors

Table 39. PledPharma AB Major Business

Table 40. PledPharma AB Liver Failure Therapeutics Product and Solutions

Table 41. PledPharma AB Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Promethera Biosciences SA Corporate Information, Head Office, and Major Competitors

Table 43. Promethera Biosciences SA Major Business

Table 44. Promethera Biosciences SA Liver Failure Therapeutics Product and Solutions

Table 45. Promethera Biosciences SA Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Silence Therapeutics Plc Corporate Information, Head Office, and Major Competitors

Table 47. Silence Therapeutics Plc Major Business

Table 48. Silence Therapeutics Plc Liver Failure Therapeutics Product and Solutions

Table 49. Silence Therapeutics Plc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Unicyte AG Corporate Information, Head Office, and Major Competitors

Table 51. Unicyte AG Major Business

Table 52. Unicyte AG Liver Failure Therapeutics Product and Solutions

Table 53. Unicyte AG Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Ventria Bioscience Corporate Information, Head Office, and Major Competitors

Table 55. Ventria Bioscience Major Business

Table 56. Ventria Bioscience Liver Failure Therapeutics Product and Solutions

Table 57. Ventria Bioscience Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Vital Therapies Inc Corporate Information, Head Office, and Major Competitors

Table 59. Vital Therapies Inc Major Business

Table 60. Vital Therapies Inc Liver Failure Therapeutics Product and Solutions

Table 61. Vital Therapies Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Global Liver Failure Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 63. Global Liver Failure Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 64. Breakdown of Liver Failure Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 65. Liver Failure Therapeutics Players Head Office, Products and Services Provided

Table 66. Liver Failure Therapeutics Mergers & Acquisitions in the Past Five Years

Table 67. Liver Failure Therapeutics New Entrants and Expansion Plans

Table 68. Global Liver Failure Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 69. Global Liver Failure Therapeutics Revenue Share by Type (2017-2022)

Table 70. Global Liver Failure Therapeutics Revenue Forecast by Type (2023-2028)

Table 71. Global Liver Failure Therapeutics Revenue by Application (2017-2022)

Table 72. Global Liver Failure Therapeutics Revenue Forecast by Application (2023-2028)

Table 73. North America Liver Failure Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 74. North America Liver Failure Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 75. North America Liver Failure Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 76. North America Liver Failure Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 77. North America Liver Failure Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 78. North America Liver Failure Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 79. Europe Liver Failure Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 80. Europe Liver Failure Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 81. Europe Liver Failure Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 82. Europe Liver Failure Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 83. Europe Liver Failure Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 84. Europe Liver Failure Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 85. Asia-Pacific Liver Failure Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 86. Asia-Pacific Liver Failure Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 87. Asia-Pacific Liver Failure Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 88. Asia-Pacific Liver Failure Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 89. Asia-Pacific Liver Failure Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 90. Asia-Pacific Liver Failure Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 91. South America Liver Failure Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 92. South America Liver Failure Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 93. South America Liver Failure Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 94. South America Liver Failure Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 95. South America Liver Failure Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 96. South America Liver Failure Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 97. Middle East & Africa Liver Failure Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 98. Middle East & Africa Liver Failure Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 99. Middle East & Africa Liver Failure Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 100. Middle East & Africa Liver Failure Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 101. Middle East & Africa Liver Failure Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 102. Middle East & Africa Liver Failure Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Liver Failure Therapeutics Picture

Figure 2. Global Liver Failure Therapeutics Revenue Market Share by Type in 2021

Figure 3. Ornithine Phenylacetate

Figure 4. MTL-CEBPA

Figure 5. F-573

Figure 6. BL-1220

Figure 7. PP-100

Figure 8. Others

Figure 9. Liver Failure Therapeutics Revenue Market Share by Application in 2021

Figure 10. Clinic Picture

Figure 11. Hospital Picture

Figure 12. Others Picture

Figure 13. Global Liver Failure Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 14. Global Liver Failure Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 15. Global Liver Failure Therapeutics Revenue Market Share by Region (2017-2028)

Figure 16. Global Liver Failure Therapeutics Revenue Market Share by Region in 2021

Figure 17. North America Liver Failure Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Europe Liver Failure Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Asia-Pacific Liver Failure Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. South America Liver Failure Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Middle East and Africa Liver Failure Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Liver Failure Therapeutics Market Drivers

Figure 23. Liver Failure Therapeutics Market Restraints

Figure 24. Liver Failure Therapeutics Market Trends

Figure 25. Alfact Innovation Recent Developments and Future Plans

Figure 26. BioLineRx Ltd Recent Developments and Future Plans

Figure 27. Cell2B Advanced Therapeutics SA Recent Developments and Future Plans

Figure 28. Conatus Pharmaceuticals Inc Recent Developments and Future Plans

Figure 29. Immune Pharmaceuticals Inc Recent Developments and Future Plans

Figure 30. Mina Therapeutics Ltd Recent Developments and Future Plans

Figure 31. Mylan NV Recent Developments and Future Plans

Figure 32. Ocera Therapeutics Inc Recent Developments and Future Plans

Figure 33. PledPharma AB Recent Developments and Future Plans

Figure 34. Promethera Biosciences SA Recent Developments and Future Plans

Figure 35. Silence Therapeutics Plc Recent Developments and Future Plans

Figure 36. Unicyte AG Recent Developments and Future Plans

Figure 37. Ventria Bioscience Recent Developments and Future Plans

Figure 38. Vital Therapies Inc Recent Developments and Future Plans

Figure 39. Global Liver Failure Therapeutics Revenue Share by Players in 2021

Figure 40. Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 41. Global Top 3 Players Liver Failure Therapeutics Revenue Market Share in 2021

Figure 42. Global Top 10 Players Liver Failure Therapeutics Revenue Market Share in 2021

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 44. Global Liver Failure Therapeutics Revenue Share by Type in 2021

Figure 45. Global Liver Failure Therapeutics Market Share Forecast by Type (2023-2028)

Figure 46. Global Liver Failure Therapeutics Revenue Share by Application in 2021

Figure 47. Global Liver Failure Therapeutics Market Share Forecast by Application (2023-2028)

Figure 48. North America Liver Failure Therapeutics Sales Market Share by Type (2017-2028)

Figure 49. North America Liver Failure Therapeutics Sales Market Share by Application (2017-2028)

Figure 50. North America Liver Failure Therapeutics Revenue Market Share by Country (2017-2028)

Figure 51. United States Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Canada Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Mexico Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Europe Liver Failure Therapeutics Sales Market Share by Type (2017-2028)

Figure 55. Europe Liver Failure Therapeutics Sales Market Share by Application (2017-2028)

Figure 56. Europe Liver Failure Therapeutics Revenue Market Share by Country (2017-2028)

Figure 57. Germany Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. France Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. United Kingdom Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Russia Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Italy Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Asia-Pacific Liver Failure Therapeutics Sales Market Share by Type (2017-2028)

Figure 63. Asia-Pacific Liver Failure Therapeutics Sales Market Share by Application (2017-2028)

Figure 64. Asia-Pacific Liver Failure Therapeutics Revenue Market Share by Region (2017-2028)

Figure 65. China Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Japan Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South Korea Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. India Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Southeast Asia Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Australia Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. South America Liver Failure Therapeutics Sales Market Share by Type (2017-2028)

Figure 72. South America Liver Failure Therapeutics Sales Market Share by Application (2017-2028)

Figure 73. South America Liver Failure Therapeutics Revenue Market Share by Country (2017-2028)

Figure 74. Brazil Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Argentina Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Middle East and Africa Liver Failure Therapeutics Sales Market Share by Type (2017-2028)

Figure 77. Middle East and Africa Liver Failure Therapeutics Sales Market Share by Application (2017-2028)

Figure 78. Middle East and Africa Liver Failure Therapeutics Revenue Market Share by Country (2017-2028)

Figure 79. Turkey Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Saudi Arabia Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. UAE Liver Failure Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz